The PAD4 inhibitor GSK484 enhances the radiosensitivity of triple-negative breast cancer (vol 40, pg 1074, 2021)L. Wei,X. Wang,M. Luo, H. Wang,H. Chen,C. HuangHUMAN & EXPERIMENTAL TOXICOLOGY（2021）引用 9|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
